Title: Supplementary Methods from SC-60, a Dimer-Based Sorafenib Derivative, Shows a Better Anti–Hepatocellular Carcinoma Effect than Sorafenib in a Preclinical Hepatocellular Carcinoma Model
Abstract:<p>PDF - 172K, Supplementary Methods</p>...<p>PDF - 172K, Supplementary Methods</p>Read More